Moreover, increased BCR in relation to obesity has been reported both in situ and in invasive tumors, and it seems to be higher for HER2-positive than HER2-negative tumors [94,95]. The gene discussed is ERBB2; the disease is obesity due to melanocortin 4 receptor deficiency.